OBJECTIVE: The aim of this study was to assess the feasibility of first-pass contrast-enhanced renal MR angiography (MRA) at 7 T. METHODS: In vivo first-pass contrast-enhanced high-field examinations were obtained in eight healthy subjects on a 7-T whole-body MRI. A custom-built body transmit/receive radiofrequency (RF) coil and RF system suitable for RF shimming were used for image acquisition. For dynamic imaging, gadobutrol was injected intravenously and coronal unenhanced, arterial and venous data sets using a T1-weighted spoiled gradient-echo sequence were obtained. Qualitative image analysis and assessment of artefact impairment were performed by two senior radiologists using a five-point scale (5 = excellent, 1 = non-diagnostic). SNR and CNR of the perirenal abdominal aorta and both main renal arteries were assessed. RESULTS: Qualitative image evaluation revealed overall high-quality delineation of all assessed segments of the unenhanced arterial vasculature (meanunenhanced 4.13). Nevertheless, the application of contrast agent revealed an improvement in vessel delineation of all the vessel segments assessed, confirmed by qualitative (meanunenhanced 4.13 to meancontrast-enhanced 4.85) and quantitative analysis (SNR meanunenhanced 64.3 to meancontrast-enhanced 98.4). CONCLUSION: This study demonstrates the feasibility and current constraints of ultra-high-field contrast-enhanced renal MRA relative to unenhanced MRA.
OBJECTIVE: The aim of this study was to assess the feasibility of first-pass contrast-enhanced renal MR angiography (MRA) at 7 T. METHODS: In vivo first-pass contrast-enhanced high-field examinations were obtained in eight healthy subjects on a 7-T whole-body MRI. A custom-built body transmit/receive radiofrequency (RF) coil and RF system suitable for RF shimming were used for image acquisition. For dynamic imaging, gadobutrol was injected intravenously and coronal unenhanced, arterial and venous data sets using a T1-weighted spoiled gradient-echo sequence were obtained. Qualitative image analysis and assessment of artefact impairment were performed by two senior radiologists using a five-point scale (5 = excellent, 1 = non-diagnostic). SNR and CNR of the perirenal abdominal aorta and both main renal arteries were assessed. RESULTS: Qualitative image evaluation revealed overall high-quality delineation of all assessed segments of the unenhanced arterial vasculature (meanunenhanced 4.13). Nevertheless, the application of contrast agent revealed an improvement in vessel delineation of all the vessel segments assessed, confirmed by qualitative (meanunenhanced 4.13 to meancontrast-enhanced 4.85) and quantitative analysis (SNR meanunenhanced 64.3 to meancontrast-enhanced 98.4). CONCLUSION: This study demonstrates the feasibility and current constraints of ultra-high-field contrast-enhanced renal MRA relative to unenhanced MRA.
Authors: Martin Rohrer; Hans Bauer; Jan Mintorovitch; Martin Requardt; Hanns-Joachim Weinmann Journal: Invest Radiol Date: 2005-11 Impact factor: 6.016
Authors: Henrik J Michaely; Harald Kramer; Olaf Dietrich; Kambiz Nael; Klaus-Peter Lodemann; Maximilian F Reiser; Stefan O Schoenberg Journal: Radiology Date: 2007-09 Impact factor: 11.105
Authors: Stefan Maderwald; Susanne C Ladd; Elke R Gizewski; Oliver Kraff; Jens M Theysohn; Karsten Wicklow; Christoph Moenninghoff; Isabel Wanke; Mark E Ladd; Harald H Quick Journal: MAGMA Date: 2008-01-04 Impact factor: 2.310
Authors: Lale Umutlu; Andreas K Bitz; Stefan Maderwald; Stephan Orzada; Sonja Kinner; Oliver Kraff; Irina Brote; Susanne C Ladd; Tobias Schroeder; Michael Forsting; Gerald Antoch; Mark E Ladd; Harald H Quick; Thomas C Lauenstein Journal: Eur J Radiol Date: 2011-08-20 Impact factor: 3.528
Authors: F De Cobelli; M Venturini; A Vanzulli; S Sironi; M Salvioni; E Angeli; P Scifo; M P Garancini; R Quartagno; G Bianchi; A Del Maschio Journal: Radiology Date: 2000-02 Impact factor: 11.105
Authors: F De Cobelli; A Vanzulli; S Sironi; R Mellone; E Angeli; M Venturini; M P Garancini; R Quartagno; G Bianchi; A Del Maschio Journal: Radiology Date: 1997-12 Impact factor: 11.105
Authors: Iris M Noebauer-Huhmann; Pavol Szomolanyi; Vladimír Juras; Oliver Kraff; Mark E Ladd; Siegfried Trattnig Journal: Invest Radiol Date: 2010-09 Impact factor: 6.016
Authors: Jurgen K Willmann; Simon Wildermuth; Thomas Pfammatter; Justus E Roos; Burkhardt Seifert; Paul R Hilfiker; Borut Marincek; Dominik Weishaupt Journal: Radiology Date: 2003-01-31 Impact factor: 11.105
Authors: Andreas Christ; Wolfgang Kainz; Eckhart G Hahn; Katharina Honegger; Marcel Zefferer; Esra Neufeld; Wolfgang Rascher; Rolf Janka; Werner Bautz; Ji Chen; Berthold Kiefer; Peter Schmitt; Hans-Peter Hollenbach; Jianxiang Shen; Michael Oberle; Dominik Szczerba; Anthony Kam; Joshua W Guag; Niels Kuster Journal: Phys Med Biol Date: 2009-12-17 Impact factor: 3.609
Authors: Karsten H Wrede; Philipp Dammann; Sören Johst; Christoph Mönninghoff; Marc Schlamann; Stefan Maderwald; I Erol Sandalcioglu; Mark E Ladd; Michael Forsting; Ulrich Sure; Lale Umutlu Journal: Eur Radiol Date: 2015-06-17 Impact factor: 5.315
Authors: Lale Umutlu; Oliver Kraff; Anja Fischer; Sonja Kinner; Stefan Maderwald; Kai Nassenstein; Felix Nensa; Johannes Grüneisen; Stephan Orzada; Andreas K Bitz; Michael Forsting; Mark E Ladd; Thomas C Lauenstein Journal: Eur Radiol Date: 2013-05-04 Impact factor: 5.315
Authors: Sören Johst; Stephan Orzada; Anja Fischer; Lena C Schäfer; Kai Nassenstein; Lale Umutlu; Thomas C Lauenstein; Mark E Ladd; Stefan Maderwald Journal: PLoS One Date: 2014-01-16 Impact factor: 3.240
Authors: Stephan Orzada; Klaus Solbach; Marcel Gratz; Sascha Brunheim; Thomas M Fiedler; Sören Johst; Andreas K Bitz; Samaneh Shooshtary; Ashraf Abuelhaija; Maximilian N Voelker; Stefan H G Rietsch; Oliver Kraff; Stefan Maderwald; Martina Flöser; Mark Oehmigen; Harald H Quick; Mark E Ladd Journal: PLoS One Date: 2019-09-12 Impact factor: 3.240
Authors: Anneloes de Boer; Johannes M Hoogduin; Peter J Blankestijn; Xiufeng Li; Peter R Luijten; Gregory J Metzger; Alexander J E Raaijmakers; Lale Umutlu; Fredy Visser; Tim Leiner Journal: MAGMA Date: 2016-03-23 Impact factor: 2.310